Published in J Gastroenterol on November 09, 2006
Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol (2009) 0.91
Prediction of microvascular invasion of hepatocellular carcinoma by pre-operative CT imaging. Br J Radiol (2011) 0.90
C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion. World J Surg Oncol (2013) 0.90
Can microvessel invasion of hepatocellular carcinoma be predicted by pre-operative MRI? Eur Radiol (2009) 0.86
Vasculogenic mimicry in hepatocellular carcinoma contributes to portal vein invasion. Oncotarget (2016) 0.77
Vascular invasion in hepatocellular carcinoma: is there a correlation with MRI? Br J Radiol (2011) 0.76
MRI features of hepatocellular carcinoma related to biologic behavior. Korean J Radiol (2015) 0.75
KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol (1989) 2.82
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer (2004) 2.03
Ring enhancement in ultrasmall superparamagnetic iron oxide MR imaging: a potential new sign for characterization of liver lesions. AJR Am J Roentgenol (1996) 2.02
Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation (2002) 1.95
Hypervascular hepatocellular carcinoma: evaluation of hemodynamics with dynamic CT during hepatic arteriography. Radiology (1998) 1.90
Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg (2002) 1.47
Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer (1996) 1.36
Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (2000) 1.33
Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res (2003) 1.23
Small arterial-portal venous shunts: a cause of pseudolesions at hepatic imaging. Radiology (1997) 1.06
Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg (2002) 1.05
Perilesional hyperintense rim of malignant hepatic tumors on ferumoxide-enhanced T1-weighted gradient-echo MR images: correlation between MR imaging and histopathologic findings. J Magn Reson Imaging (2003) 0.99
Poor prognostic factors of hepatectomy in patients with resectable small hepatocellular carcinoma and cirrhosis. J Cancer Res Clin Oncol (2004) 0.98
Sensitivity in detection of hypervascular hepatocellular carcinoma by helical CT with intra-arterial injection of contrast medium, and by helical CT and MR imaging with intravenous injection of contrast medium. Acta Radiol (1998) 0.96
Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. Arch Pathol Lab Med (1995) 0.96
Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide. AJR Am J Roentgenol (2000) 0.95
Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced mr imaging versus combined helical CT during arterial portography and CT hepatic arteriography. AJR Am J Roentgenol (2001) 0.91
Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization. Cardiovasc Intervent Radiol (2001) 0.90
Segmental intensity differences in the liver on MR images: a sign of intrahepatic portal flow stoppage. Radiology (1988) 0.90
Superparamagnetic iron oxide-enhanced MR imaging for early and late radiation-induced hepatic injuries. Magn Reson Imaging (2000) 0.82
Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography. J Gastroenterol (2005) 0.82
Improved tissue characterization of focal liver lesions with ferumoxide-enhanced T1 and T2-weighted MR imaging. J Magn Reson Imaging (2000) 0.81
Computed tomography during arteriography and arterial portography in small hepatocellular carcinoma and dysplastic nodule: a prospective study. Jpn J Cancer Res (2000) 0.78
Pseudolesions at T1-weighted gradient-echo imaging after administration of superparamagnetic iron oxide: comparison with portal perfusion abnormalities at CT during arterial portography. Radiology (1998) 0.76
Hepatic resection of hepatocellular carcinomas based on tumor hemodynamics. J Surg Oncol (2000) 0.75
The mechanism of ring enhancement in hepatocellular carcinoma on superparamagnetic iron oxide-enhanced T1-weighted images: an investigation into peritumoral Kupffer cells. J Magn Reson Imaging (2005) 0.75
The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg (2009) 5.33
Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology (2008) 2.31
Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med (2002) 2.18
Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis. Nat Med (2006) 2.03
Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines. Cancer Sci (2008) 2.01
Evaluation of pathogen detection from clinical samples by real-time polymerase chain reaction using a sepsis pathogen DNA detection kit. Crit Care (2010) 1.81
Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncol Rep (2012) 1.81
Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol (2013) 1.79
Percutaneous cryoablation of lung tumors: feasibility and safety. J Vasc Interv Radiol (2012) 1.73
Bilirubin rinse: A simple protectant against the rat liver graft injury mimicking heme oxygenase-1 preconditioning. Hepatology (2003) 1.69
Molecular detection of sentinel node micrometastases in patients with clinical N0 gastric carcinoma with real-time multiplex reverse transcription-polymerase chain reaction assay. Ann Surg Oncol (2011) 1.63
Validation study of radio-guided sentinel lymph node navigation in esophageal cancer. Ann Surg (2009) 1.62
Operative indications for relatively small (2-5 cm) gastrointestinal stromal tumor of the stomach based on analysis of 60 operated cases. Surgery (2006) 1.61
Percutaneous cryoablation for pulmonary nodules in the residual lung after pneumonectomy: report of two cases. Chest (2011) 1.57
Role of high mobility group box chromosomal protein 1 in ischemia-reperfusion injury in the rat small intestine. J Surg Res (2012) 1.54
Minimally invasive donor hepatectomy: evolution from hybrid to pure laparoscopic techniques. Ann Surg (2015) 1.52
EMR of a hyperplastic polyp arising in ectopic gastric mucosa in the cervical esophagus: case report. Gastrointest Endosc (2005) 1.51
Overexpression of leucine-rich repeat-containing G protein-coupled receptor 5 in colorectal cancer. Cancer Sci (2010) 1.49
Biliary complications in adult living donor liver transplantation with duct-to-duct hepaticocholedochostomy or Roux-en-Y hepaticojejunostomy biliary reconstruction. Surgery (2002) 1.48
Tailored laparoscopic resection for suspected gastric gastrointestinal stromal tumors. Surgery (2009) 1.46
Pretreatment plasma fibrinogen level correlates with tumor progression and metastasis in patients with squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol (2007) 1.46
Clinical significance of circulating tumor cells in blood from patients with gastrointestinal cancers. Ann Surg Oncol (2008) 1.46
Prognostic value of cardiac magnetic resonance imaging for idiopathic pulmonary arterial hypertension before initiating intravenous prostacyclin therapy. Circ J (2012) 1.45
Colorectal motility induction by sacral nerve electrostimulation in a canine model: implications for colonic pacing. Dis Colon Rectum (2003) 1.43
Biliary findings assist in predicting enlargement of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol (2012) 1.43
Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol (2009) 1.42
Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. J Clin Invest (2010) 1.42
Cribriform-morular variant of papillary thyroid carcinoma: ultrastructural study and somatic/germline mutation analysis of the APC gene. Ultrastruct Pathol (2004) 1.40
A novel apoptosis-inducing monoclonal antibody (anti-LHK) against a cell surface antigen on colon cancer cells. J Gastroenterol (2005) 1.39
The relationship between bone metastasis from human breast cancer and integrin alpha(v)beta3 expression. Anticancer Res (2005) 1.38
Minimally invasive surgery for gastric cancer: the future standard of care. World J Surg (2011) 1.37
Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer. Urology (2004) 1.34
Laparoscopic major hepatectomy: a systematic literature review and comparison of 3 techniques. Ann Surg (2013) 1.33
Downregulation of miR-144 is associated with colorectal cancer progression via activation of mTOR signaling pathway. Carcinogenesis (2012) 1.33
Current state of gastric stump carcinoma in Japan: based on the results of a nationwide survey. World J Surg (2010) 1.32
Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res (2005) 1.31
Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis. World J Surg (2006) 1.30
Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma. World J Surg (2007) 1.29
Current progress in ABO-incompatible liver transplantation. Eur J Clin Invest (2010) 1.26
Surgical treatment of esophageal cancer--the advent of the era of individualization. N Engl J Med (2002) 1.24
Pseudoaneurysm of the cystic artery secondary to cholecystitis as a cause of hemobilia: report of a case. Surg Today (2007) 1.23
International experience for laparoscopic major liver resection. J Hepatobiliary Pancreat Sci (2014) 1.23
Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation (2002) 1.20
Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas. J Pathol (2009) 1.20
A novel difficulty scoring system for laparoscopic liver resection. J Hepatobiliary Pancreat Sci (2014) 1.17
Skill accreditation system for laparoscopic gastroenterologic surgeons in Japan. Minim Invasive Ther Allied Technol (2010) 1.17
A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery. J Hepatobiliary Pancreat Sci (2012) 1.16
Sentinel lymph node as a target of molecular diagnosis of lymphatic micrometastasis and local immunoresponse to malignant cells. Cancer Sci (2007) 1.16
Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet? Surgery (2009) 1.16
Signet-ring cell carcinoma of the ampulla of Vater: report of a case. Surg Today (2007) 1.15
Can endoscopic ultrasonography differentiate nonneoplastic from neoplastic gallbladder polyps? Dig Dis Sci (2006) 1.15
Laparoscopy-assisted major liver resections employing a hanging technique: the original procedure. Ann Surg (2010) 1.14
Laparoscopic subtotal cholecystectomy for severe cholecystitis. Surg Today (2009) 1.14
xCT inhibition depletes CD44v-expressing tumor cells that are resistant to EGFR-targeted therapy in head and neck squamous cell carcinoma. Cancer Res (2013) 1.13
Advanced gastric endocrine cell carcinoma with distant lymph node metastasis: a case report and clinicopathological characteristics of the disease. Gastric Cancer (2004) 1.13
Successful treatment of non-occlusive mesenteric ischemia (NOMI) using the HyperEye Medical System™ for intraoperative visualization of the mesenteric and bowel circulation: report of a case. Surg Today (2013) 1.13
Liver regeneration in donors and adult recipients after living donor liver transplantation. Liver Transpl (2008) 1.13
Expression of Snail and Slug in renal cell carcinoma: E-cadherin repressor Snail is associated with cancer invasion and prognosis. Lab Invest (2011) 1.12
Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Res Treat (2010) 1.11
Metachronous gastric carcinoma from a gastric tube after radical surgery for esophageal carcinoma. Ann Thorac Surg (2004) 1.11
Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS One (2012) 1.11
Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol (2005) 1.11
The risk of lymph node metastasis in T1 colorectal carcinoma. Hepatogastroenterology (2004) 1.11
Calcium-induced generation of reactive oxygen species in brain mitochondria is mediated by permeability transition. Free Radic Biol Med (2008) 1.10
Gallstone disease after extended (D2) lymph node dissection for gastric cancer. World J Surg (2005) 1.10
Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition. Int J Clin Oncol (2010) 1.09
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res (2006) 1.08
Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates. J Thorac Cardiovasc Surg (2006) 1.08
Overexpression of cyclase-associated protein 2 in multistage hepatocarcinogenesis. Clin Cancer Res (2006) 1.07
Biexponential apparent diffusion coefficients in prostate cancer. Magn Reson Imaging (2008) 1.07
Endoscopic thyroidectomy by the breast approach: a single institution's 9-year experience. World J Surg (2008) 1.07
Diagnosis and treatment of a gastric hamartomatous inverted polyp: report of a case. Surg Today (2004) 1.07
Application of the HyperEye Medical System for esophageal cancer surgery: a preliminary report. Surg Today (2012) 1.07
ADAM28 is overexpressed in human breast carcinomas: implications for carcinoma cell proliferation through cleavage of insulin-like growth factor binding protein-3. Cancer Res (2006) 1.07
Comparative Short-term Benefits of Laparoscopic Liver Resection: 9000 Cases and Climbing. Ann Surg (2016) 1.06
Minimally invasive surgery for gastric cancer--toward a confluence of two major streams: a review. Gastric Cancer (2005) 1.05